Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A11CC05	D-CURE	G	Vitamin D3 - 25,000IU	25,000IU	Solution	467,657 L.L
A11CC05	DIBASE	G	Vitamin D3 - 50000IU/2.5ml	50,000IU/2.5ml	Solution	755,239 L.L
D11AF	VERRUMAL	B	Fluorouracil - 0.5g/100g, Salicylic acid - 10g/100g		Solution	529,474 L.L
N06AX27	SPRAVATO	B	Esketamine - 28mg/device	28mg/device	Solution	25,122,440 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	66,978,978 L.L
D11AX01	ALOPEXY	G	Minoxidil - 20mg/ml	2%	Solution	532,162 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	44,561,381 L.L
D11AX01	ALOPEXY	G	Minoxidil - 2%	2%	Solution	532,162 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	25,122,440 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 2%	2%	Solution	2,839,539 L.L
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L
D11AX01	ALOPEXY	G	Minoxidil - 50mg/ml	5%	Solution	896,343 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
D11AX01	HAIRGAINE 5	G	Minoxidil - 5%	5%	Solution	1,963,354 L.L
D11AX01	HAIRGROW	G	Minoxidil - 5%	5%	Solution	1,061,636 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 3%	3%	Solution	163,949 L.L
H01BA02	NICTUR	G	Desmopressin acetate - 360mcg/ml	360mcg/ml	Solution	5,270,550 L.L
N06BX06	CEROLINE	G	Citicoline - 100mg/ml	100mg/ml	Solution	894,615 L.L
N06BX06	SOMAZINA	B	Citicoline - 1000mg/sachet	1000mg/sachet	Solution	974,286 L.L
S01EB02	MIOSTAT STERIL INTRAOCULAR	B	Carbachol - 0.01%	0.01%	Solution	8,117,591 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/ml	0.01g/ml	Solution	368,213 L.L
L04AD01	SANDIMMUN NEORAL	B	Ciclosporin - 100mg/ml	100mg/ml	Solution	8,264,592 L.L
A13A	POTENCIATOR	G	Arginine Aspartate - 5g/10ml	5g	Solution	1,402,972 L.L
A15	DESARROL	G	Cyproheptadine HCl - 0.2mg/ml, L-Arginine L-Aspartate - 25mg/ml, L-Carnitine - 50mg/ml		Solution	1,007,882 L.L
A15A	DYNAMOGEN	G	Arginine Aspartate - 1g/10ml, Glutodine (Cyproheptadine ?-ketoglutarate) - 3mg/10ml		Solution	1,019,976 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	506,629 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Solution	355,798 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10ml/ml	1%	Solution	159,917 L.L
S01EE05	TAFLUPRO	G	Tafluprost - 0.0015%	0.0015%	Solution	1,912,288 L.L